Stock Earnings
Investing in ProKidney Corp (PROK) Is Getting More Attractive
ProKidney Corp’s recent filing unveils that its SVP of Regulatory Development Weber Darin J. unloaded Company’s shares for reported $41315.0
Menu
ProKidney Corp’s recent filing unveils that its SVP of Regulatory Development Weber Darin J. unloaded Company’s shares for reported $41315.0
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
ProKidney Corp’s filing revealed that its SVP of Regulatory Development Weber Darin J. unloaded Company’s shares for reported $41315.0 on
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
ProKidney Corp’s recent filing unveils that its SVP of Regulatory Development Weber Darin J. unloaded Company’s shares for reported $41315.0
ProKidney Corp’s recently made public that its SVP of Regulatory Development Weber Darin J. unloaded Company’s shares for reported $43095.0
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
ProKidney Corp’s recently made public that its Former 10% Owner Palihapitiya Chamath unloaded Company’s shares for reported $9.5 million on
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. ProKidney Corp